Telo Genomics Corp.
TELO.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 23.97% | 10.67% | 4.86% | -11.16% | -22.36% |
| Total Depreciation and Amortization | -32.89% | -7.94% | 18.22% | 18.75% | -0.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -125.36% | -89.87% | -65.28% | -7.35% | -3.32% |
| Change in Net Operating Assets | 215.26% | 472.32% | 57,700.00% | 239.94% | 385.85% |
| Cash from Operations | 28.66% | 20.34% | 7.32% | -7.64% | -20.52% |
| Capital Expenditure | 92.80% | 94.20% | 92.69% | 95.79% | 51.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.80% | 94.20% | 92.69% | 95.79% | 51.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00% | -200.00% | -200.00% | -- | -- |
| Issuance of Common Stock | 12.77% | -77.54% | -77.54% | 4,623.17% | 4,623.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.16% | 81.70% | 80.48% | -- | -- |
| Cash from Financing | 7.40% | -78.40% | -78.50% | 4,269.00% | 4,306.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 880.76% | -1,092.25% | -7,504.92% | 98.90% | 94.96% |
